All Stories

  1. Creating and Testing New Drugs to Fight Breast Cancer by Blocking LPA1 Receptors

    Article • Future Medicinal Chemistry, April 2024, Taylor & Francis

    Dr Gurubasavaraj V Pujar

  2. Developing and Testing New Compounds to Fight Breast Cancer by Targeting LPA1 Receptors

    Article • Journal of Molecular Structure, January 2024, Elsevier

    Dr Gurubasavaraj V Pujar

  3. New Anti-HIV Drugs: Designing and Testing 1,3-Thiazolidine Pyrimidine Compounds

    Article • Journal of Molecular Structure, December 2023, Elsevier

    Dr Gurubasavaraj V Pujar

  4. Restoration of p53 functions by suppression of mortalin–p53 sequestration: an emerging target in cancer therapy

    Article • Future Medicinal Chemistry, November 2023, Future Science

    Dr Gurubasavaraj V Pujar

  5. Novel Antitubercular Agents: Design, Synthesis, Molecular Dynamic and Biological Studies of Pyrazole – 1,2,4‐Triazole Conjugates

    Article • Chemistry & Biodiversity, October 2023, Wiley

    Dr Gurubasavaraj V Pujar

  6. Evolution of Machine Learning in Tuberculosis Diagnosis: A Review of Deep Learning-Based Medical Applications

    Article • Electronics, August 2022, MDPI AG

    Dr Gurubasavaraj V Pujar

  7. Machine learning and deep learning in data-driven decision making of drug discovery and challenges in high-quality data acquisition in the pharmaceutical industry

    Article • Future Medicinal Chemistry, February 2022, Future Science

    Dr Gurubasavaraj V Pujar

  8. Mass Spectrometry (MS/MS) and Proteomics

    Article • Mini-Reviews in Organic Chemistry, November 2021, Bentham Science Publishers

    Dr Gurubasavaraj V Pujar, Dr Swathi Naraparaju, Durai Ananda Kumar T

  9. Dengue structural proteins as antiviral drug targets: Current status in the drug discovery & development

    Article • European Journal of Medicinal Chemistry, October 2021, Elsevier

    Dr Gurubasavaraj V Pujar

  10. Lysophosphatidic acid (LPA) receptor modulators: Structural features and recent development

    Article • European Journal of Medicinal Chemistry, October 2021, Elsevier

    Dr Gurubasavaraj V Pujar

  11. Antitubercular Potential of Novel Isoxazole Encompassed 1, 2, 4- Triazoles: Design, Synthesis, Molecular Docking Study and Evaluation of Antitubercular Activity

    Article • Anti-Infective Agents, May 2021, Bentham Science Publishers

    Dr Gurubasavaraj V Pujar

  12. Molecular Docking and Three‐Dimensional Quantitative Structure–Activity Relationships for Antitubercular Pyrimidine Derivatives

    Article • Polycyclic Aromatic Compounds, February 2021, Taylor & Francis

    Dr Gurubasavaraj V Pujar

  13. Design, Synthesis and Antitubercular Evaluation of New Benzimidazole Scaffolds

    Article • Anti-Infective Agents, January 2021, Bentham Science Publishers

    Dr Gurubasavaraj V Pujar

  14. Design, synthesis, and cytotoxicity evaluation of new 2,4-disubstituted quinazolines as potential anticancer agents

    Article • Journal of Applied Biology & Biotechnology, August 2020, Journal of Applied Pharmaceutical Science

    Dr Gurubasavaraj V Pujar

  15. New benzothiazinone linked 1, 2, 4-triazoles: Design, synthesis, characterization, and evaluation of antitubercular activity

    Article • Journal of Applied Biology & Biotechnology, February 2020, Journal of Applied Pharmaceutical Science

    Dr Gurubasavaraj V Pujar

  16. Synthesis and in vitro Cytotoxicity Study of Novel 4-Substituted Quinazolines Encompassed with Thiazolidinone and Azetidinone

    Article • Asian Journal of Chemistry, January 2020, Asian Journal of Chemistry

    Dr Gurubasavaraj V Pujar

  17. Inclusion Complexes of Nateglinide with HP–β–CD and L-Arginine for Solubility and Dissolution Enhancement: Preparation, Characterization, and Molecular Docking Study

    Article • Journal of Pharmaceutical Innovation, March 2017, Springer Science + Business Media

    Dr Gurubasavaraj V Pujar, Manikanta Murahari

  18. Recent Advances and Structural Features of Enoyl-ACP Reductase Inhibitors of Mycobacterium tuberculosis

    Article • Archiv der Pharmazie, October 2016, Wiley

    Dr Gurubasavaraj V Pujar

  19. Synthesis of 1,3,4-oxadiazoles as promising anticoagulant agents

    Article • RSC Advances, January 2016, Royal Society of Chemistry

    Dr Gurubasavaraj V Pujar

  20. Design, synthesis and evaluation of diphenyl ether analogues as antitubercular agents

    Article • RSC Advances, January 2016, Royal Society of Chemistry

    Dr Gurubasavaraj V Pujar

  21. Synthesis and Evaluation of New 5-methylisoxazole-3-carboxamide Derivatives as Antitubercular Agents

    Article • Anti-Infective Agents, October 2015, Bentham Science Publishers

    Dr Gurubasavaraj V Pujar

  22. Structural insights of PA-824 derivatives: ligand-based 3D-QSAR study and design of novel PA824 derivatives as anti-tubercular agents

    Article • Journal of Receptors and Signal Transduction, June 2015, Taylor & Francis

    Dr Gurubasavaraj V Pujar

  23. Synthesis and crystal structure of 2-{5-[2-(2,6-dichlorophenylamino)benzyl]-4-p-tolyl-4H-1,2,4-triazol-3-ylthio}acetate

    Article • Journal of Saudi Chemical Society, November 2014, Elsevier

    Dr Gurubasavaraj V Pujar

  24. Design, synthesis and 3D-QSAR studies of new diphenylamine containing 1,2,4-triazoles as potential antitubercular agents

    Article • European Journal of Medicinal Chemistry, September 2014, Elsevier

    Dr Gurubasavaraj V Pujar

  25. Synthesis, in vitro cytotoxicity, and antibacterial studies of new asymmetric bis-1,2,4-triazoles

    Article • Medicinal Chemistry Research, September 2012, Springer Science + Business Media

    Dr Gurubasavaraj V Pujar

  26. Synthesis and Pharmacological Evaluation of 7-chloro-6-fluoro-2-(5-aminooxazol/thiazol-2-aryldenylamino)-benzo(1,3)thiazoles

    Article • Journal of Scientific Research, December 2010, Bangladesh Journals Online (BanglaJOL)

    Dr Gurubasavaraj V Pujar